BorgWarner VP granted 30,214 shares in Form 4/A

BorgWarner Inc. vice president Stefan Demmerle reported an equity award of 30,214 shares of common stock on February 4, 2025, at a price of $0.0000 per share.

Rhea-AI Filing Summary

BorgWarner Inc. vice president Stefan Demmerle reported an equity award of 30,214 shares of common stock on February 4, 2025, at a price of $0.0000 per share. After this grant, he beneficially owned 238,771.69 shares on a direct basis.

According to the vesting terms, 50% of the shares will vest on February 28, 2027 and 100% on February 28, 2028, tying the award to multi-year service and performance. This Form 4/A is an amendment that corrects an overstatement of the number of shares previously reported as acquired in this exempt transaction on a filing dated February 6, 2025.

Insider Trade Summary

Grant/Award: 30,214 shares

Grant/Award 1 txn

Insider Demmerle Stefan

Role Vice President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,214	$0.00	$0.00

Holdings After Transaction: Common Stock — 238,771.69 shares (Direct)

Footnotes (1)

1. F1. The shares will vest 50% on February 28, 2027 and 100% on February 28, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BorgWarner (BWA) report for its vice president?

BorgWarner vice president Stefan Demmerle reported receiving 30,214 shares of common stock. The transaction occurred on February 4, 2025 at a reported price of $0.0000 per share as an exempt equity award, increasing his directly held beneficial ownership.

How many BorgWarner (BWA) shares does the reporting officer own after this Form 4/A?

Following the reported transaction, Stefan Demmerle beneficially owns 238,771.69 shares of BorgWarner common stock. These shares are listed as directly owned, reflecting his updated position after the corrected equity grant disclosed in the amended filing.

What is the vesting schedule for the 30,214 BorgWarner (BWA) shares granted?

The 30,214 shares vest in two stages over three years. Fifty percent of the shares vest on February 28, 2027, and the remaining amount vests on February 28, 2028, aligning the award with longer-term service and performance at the company.

Why did BorgWarner file this Form 4/A amendment for its officer?

The Form 4/A was filed to correct an overstatement of the shares acquired. The company notes that the amendment adjusts the amount previously reported for the exempt equity transaction originally disclosed in a filing dated February 6, 2025.

Was cash paid for the BorgWarner (BWA) shares reported in this insider filing?

No cash consideration was reported for the 30,214 shares. The transaction lists a price of $0.0000 per share, indicating an equity award or grant rather than an open-market purchase, consistent with typical executive compensation structures.

Who signed the BorgWarner (BWA) Form 4/A related to this insider grant?

The Form 4/A was signed by Miyuki P. Oshima as attorney-in-fact for Stefan Demmerle. This means an authorized representative executed the filing on the reporting person’s behalf using a previously granted power of attorney.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/05/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Demmerle Stefan

(Last) (First) (Middle)

3850 HAMLIN ROAD

(Street)

AUBURN HILLS MI 48326

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BORGWARNER INC [ BWA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
02/06/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/04/2025		A		30,214(1)	A	$0.0000	238,771.69	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares will vest 50% on February 28, 2027 and 100% on February 28, 2028.

Remarks:

This amendment corrects the overstatement of the amount of securities acquired in the exempt transaction as originally reported on the Form 4 filed on 02/06/2025.

	Miyuki P. Oshima as attorney-in-fact for Stefan Demmerle	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.